Gaurav Aggarwal, MD

Managing Director, Vivo Capital

Gaurav Aggarwal, MD, brings decades of experience investing in private and public biopharmaceutical and medical device companies across the development spectrum. He currently serves as a Managing Director at Vivo Capital, a healthcare focused investment firm where he focuses on investments in life science companies. Previously, Dr. Aggarwal served as the Chief Business Officer of Ocera Therapeutics, Inc. He has also served as Managing Director with Investor Growth Capital, Principal and Partner with Panorama Capital, a venture capital fund, and Associate at JPMorgan Partners. Prior to joining JP Morgan Partners, LLC, Dr. Aggarwal focused on venture capital investments in biopharmaceutical and medical device companies at KBL Healthcare Ventures and Wasserstein Perrella & Co. He currently also serves on the board of Geron Corporation and previously served on the boards of of directors of Sierra Oncology, Inc. (acquired by GlaxoSmithKline plc), Hyperion Therapeutics, Inc. (acquired by Horizon Pharma) and Microlin Bio, Inc.

Dr. Aggarwal received his M.D. from Columbia University, College of Physicians & Surgeons, and his B.S. in Agricultural Economics from Cornell University.